Evidence map›Paper›PMID 42848513›Full record

ArticleSTAR protocols2026

Protocol for scalable production of orally deliverable R-spondin1-loaded small extracellular vesicles for WNT-signaling activation and tissue regeneration.

Lingyan Yang, Ting Jiang, Shixiang Wang, Yue Yang, Zhiping Qiao, Yun-Shen Chan

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lingyan YangThe Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province 510150, China; Guangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China. Electronic address: yang_lingyan@gzlab.ac.cn.
Ting JiangGuangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, China.
Shixiang WangGuangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province 510080, China.
Yue YangGuangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, China.
Zhiping QiaoGuangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province 510080, China.
Yun-Shen ChanThe Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province 510150, China; Guangzhou National Laboratory, Guangzhou, Guangdong Province 510005, China. Electronic address: chan_yunshen@gzlab.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

R-spondin1 plays a pivotal role in potentiating canonical WNT/β-catenin signaling, a pathway critical for maintaining stem cell homeostasis and driving tissue regeneration. Here, we present a scalable, serum-free protocol for producing R-spondin1-loaded small extracellular vesicles (evRSPO1) from engineered HEK293 cells, with multimodal characterization of vesicle quality and bioactivity. We also describe steps for in vitro functional validation of the vesicles using mouse intestinal organoids and for in vivo therapeutic applications in mouse intestinal regeneration via oral delivery. For complete details on the use and execution of this protocol, please refer to Yang et al.

Indexed as

OrganoidsStem CellsTissue Engineering

Identifiers

PMID42848513
PMCPMC13676708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.